- Tytuł:
- Efficacy and safety of upadacitinib in patients with ankylosing spondylitis refractory to biologic therapy: 1-year results from the open-label extension of a phase III study
- Autorzy:
- Źródło:
- Arthritis Research & Therapy. 25(1)
Czasopismo naukowe